MIRM Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

03

Fiyat $82.93

Piyasa Değeri (MRQ) $5.37B

P/E (TTM) -5.7

Hisse Başına Kâr (TTM) $-14.54

Gelir (TTM) $618M

ROE (TTM) -703.0%

52 Haftlık Aralık $63–$130

MIRM Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

04

aralık

çubuklar

Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.

Mirum Pharmaceuticals, Inc. - common stock Hakkında Wikipedia'dan şirket genel bakışı

05 · wikidata

Wikidata ↗

sektörHealthcare endüstriBiotechnology çalışanlar433 ülkeUS

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

06

Gelir$521M

2020-12-31 → 2025-12-31

Hisse Başına Kâr$-0.47

2021-12-31 → 2025-12-31

Serbest Nakit Akışı$55M

2019-12-31 → 2025-12-31

Net kar marjı-139.2%

2021-12-31 → 2025-12-31

Değerleme ve Oranlar 07–12

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik	MIRM	5Y ort.	Akran Ortalaması	Sonuç
P/E (TTM)	-5.75Y ort. ≈-41.7	≈-41.7	·	·
F/S (TTM)	8.75Y ort. ≈11.2	≈11.2	15.4	Düşük değerli
F/D (MRQ)	-515.35Y ort. ≈7.3	≈7.3	·	·
Fiyat / Serbest Nakit Akışı (TTM)	-23.55Y ort. ≈52.0	≈52.0	·	·
Fiyat / Nakit Akışı (TTM)	-23.65Y ort. ≈47.6	≈47.6	·	·
Fiyat / Maddi Defter Değeri (MRQ)	-20.85Y ort. ≈29.9	≈29.9	·	·

Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik	MIRM	5Y ort.	Akran Ortalaması	Sonuç
Faaliyet Kâr Marjı (TTM)	-134.9%5Y ort. ≈-233.0%	≈-233.0%	-38.2%	En üst düzey
FAVÖK Marjı (TTM)	-130.7%5Y ort. ≈-228.1%	≈-228.1%	-38.2%	En üst düzey
Vergi Öncesi Kar Marjı (TTM)	-138.7%5Y ort. ≈-148.0%	≈-148.0%	-37.2%	Aynı seviyede
Net Kâr Marjı (TTM)	-139.2%5Y ort. ≈-146.6%	≈-146.6%	-42.9%	Aynı seviyede
ROA (TTM)	-97.2%5Y ort. ≈-24.5%	≈-24.5%	-22.3%	En üst düzey
ROE (TTM)	-703.0%5Y ort. ≈-58.4%	≈-58.4%	-35.2%	En üst düzey
ROIC	-7.7%5Y ort. ≈-64.7%	≈-64.7%	-30.0%	En üst düzey

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik	5 Yıllık trend	MIRM	5Y ort.	Akran Ortalaması	Sonuç
Cari Oran (MRQ)		2.95Y ort. ≈3.4	≈3.4	7.7	Düşük likidite
Cari Oran (MRQ)		2.65Y ort. ≈3.2	≈3.2	3.5	Düşük likidite

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Metrik	5 Yıllık trend	MIRM	5Y ort.	Akran Ortalaması	Sonuç
Revenue YoY (Gelir Yıllık Bazda)		54.7%5Y ort. ≈145.0%	≈145.0%	·	·
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)		89.1%	·	·	·

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik	MIRM	5Y ort.	Akran Ortalaması	Sonuç
EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))	$-0.475Y ort. ≈$-2.62	≈$-2.62	·	·
Revenue / Share (Hisse Başına Gelir)	$10.395Y ort. ≈$6.08	≈$6.08	·	·
Cash Flow / Share (Hisse Başına Nakit Akışı)	$1.115Y ort. ≈$-0.99	≈$-0.99	·	·
Cash / Share (Hisse Başına Nakit)	$5.725Y ort. ≈$3.65	≈$3.65	·	·

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik	MIRM	5Y ort.	Akran Ortalaması	Sonuç
Asset Turnover (Aktif Devir Hızı)	0.75Y ort. ≈0.4	≈0.4	0.2	En üst düzey
Receivables Turnover (Alacak Devir Hızı)	5.25Y ort. ≈6.2	≈6.2	8.4	Zayıf
Revenue / Employee (Çalışan Başına Gelir)	≈$1.2M	·	·	·

değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

14

Ort. Sürpriz -63.1%

Sonraki Rapor Kas 04, 2026

Dönem	Rapor	EPS Gerçek	EPS Tahmin	Sürpriz
30 Haziran 2026	Ağu 4, 2026	$-1.06	$-0.69	-52.6%
31 Mart 2026		$-1.08	$-0.36	-199.7%
31 Aralık 2025		$-0.10	$0.04	-330.9%
30 Eylül 2025		$0.05	$-0.17	129.8%
30 Haziran 2025		$-0.12	$-0.33	64.0%
31 Mart 2025		$-0.30	$-0.34	10.7%

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

15

Gelir Tablosu 14

Metrik	2025	2024	2023	2022	2021	2020
Revenue	$521M	$337M	$186M	$77M	$19M	$0
SG&A Expense	$257M	$202M	$146M	$89M	$59M	$23M
Operating Expenses	$543M	$424M	$296M	$208M	$193M	$104M
Operating Income	$-22M	$-88M	$-109M	$-131M	$-173M	$-104M
Interest Income	$13M	$14M	$14M	$4M	$366.0K	$2M
Other Non-op	$2M	$1M	$-3M	$365.0K	$-582.0K	$-192.0K
Pretax Income	$-21M	$-87M	$-162M	$-142M	$-84M	$-103M
Income Tax	$2M	$1M	$991.0K	$-6M	$37.0K	$6.0K
Net Income	$-23M	$-88M	$-163M	$-136M	$-84M	$-103M
EPS (Basic)	$-0.47	$-1.85	$-4.00	$-4.01	$-2.77	·
EPS (Diluted)	$-0.47	$-1.85	$-4.00	$-4.02	$-2.77	·
Shares (Basic)	50,198,304	47,522,594	40,885,124	33,839,072	30,321,722	·
Shares (Diluted)	50,198,304	47,522,594	40,885,124	33,982,493	30,321,722	·
EBITDA	$2M	$-64M	$-98M	$-128M	$-173M	$-104M

Bilanço 23

Metrik	2025	2024	2023	2022	2021	2020
Cash & Equivalents	$297M	$223M	$286M	$28M	$31M	$142M
Short-term Investments	$87M	$58M	$0	$124M	$125M	$90M
Receivables	$123M	$78M	$68M	$24M	$3M	$0
Inventory	$25M	$22M	$22M	$6M	$2M	$0
Prepaid Expense	$18M	$12M	$11M	$9M	$5M	$5M
Current Assets	$550M	$393M	$388M	$190M	$167M	$236M
PP&E (Net)	$2M	$1M	$706.0K	$914.0K	$981.0K	$1M
Accum. Depreciation	$1M	$700.0K	$2M	$1M	$700.0K	$300.0K
Intangibles	$261M	$250M	$253M	$59M	$19M	$0
Other Non-current Assets	$12M	$5M	$4M	$1M	$2M	$1M
Total Assets	$843M	$671M	$647M	$353M	$295M	$241M
Accounts Payable	$10M	$15M	$7M	$9M	$9M	$3M
Accrued Liabilities	$196M	$112M	$79M	$54M	$31M	$13M
Current Liabilities	$206M	$127M	$87M	$65M	$43M	$18M
Capital Leases	$8M	$8M	$617.0K	$1M	$2M	$3M
Other Non-current Liabilities	$5M	$3M	$4M	$5M	$17.0K	$29.0K
Total Liabilities	$528M	$445M	$398M	$211M	$174M	$69M
Common Stock	$5.0K	$5.0K	$5.0K	$4.0K	$3.0K	$3.0K
Retained Earnings	$-668M	$-644M	$-556M	$-393M	$-257M	$-173M
AOCI	$351.0K	$-373.0K	$2M	$-217.0K	$-35.0K	$83.0K
Stockholders' Equity	$315M	$226M	$249M	$142M	$120M	$172M
Liabilities + Equity	$843M	$671M	$647M	$353M	$295M	$241M
Shares Outstanding	51,896,391	48,338,096	46,723,143	36,956,345	30,582,596	29,776,544

Nakit Akışı 14

Metrik	2025	2024	2023	2022	2021	2020
D&A	$24M	$24M	$11M	$3M	$595.0K	$305.0K
Stock-based Comp	$71M	$48M	$35M	$27M	$23M	$13M
Deferred Tax	$0	$0	$0	$-7M	$0	·
Amort. of Intangibles	$24M	$23M	$10M	$3M	$300.0K	·
Other Non-cash	$-16M	$26M	$47M	$-8M	$-72M	$1M
Operating Cash Flow	$56M	$10M	$-71M	$-120M	$-133M	$-89M
CapEx	$954.0K	$993.0K	$109.0K	$278.0K	$24.0K	$225.0K
Investing Cash Flow	$-24M	$-90M	$-107M	$8M	$49M	$38M
Stock Issued	$0	$0	$14M	$21M	$0	·
Net Stock Activity	$0	$0	$14M	$21M	·	·
Financing Cash Flow	$40M	$18M	$337M	$109M	$73M	$181M
Net Change in Cash	$75M	$-63M	$158M	$-3M	$-11M	$130M
Taxes Paid	$2M	$1M	$125.0K	$0	·	·
Free Cash Flow	$55M	$9M	$-71M	$-120M	$-133M	$-89M

Kârlılık 7

Metrik	2025	2024	2023	2022	2021	2020
Operating Margin	-4.2%	-26.0%	-58.6%	-170.3%	-906.1%	·
Net Margin	-4.5%	-26.1%	-87.7%	-176.0%	-438.8%	·
Pretax Margin	-4.1%	-25.8%	-87.2%	-184.4%	-438.7%	·
EBITDA Margin	0.40%	-19.0%	-52.8%	-166.1%	-903.0%	·
ROA	-3.1%	-13.4%	-32.7%	-41.9%	-31.4%	-53.3%
ROE	-8.2%	-38.4%	-63.1%	-87.2%	-95.1%	-70.7%
ROIC	-7.7%	-39.3%	-44.2%	-88.2%	-144.3%	-60.6%

Likidite ve Solventlik 2

Metrik	Eğilim	2025	2024	2023	2022	2021	2020
Current Ratio		2.7	3.1	4.5	2.9	3.9	12.8
Quick Ratio		2.5	2.8	4.1	2.7	3.8	12.6

Verimlilik 2

Metrik	Eğilim	2025	2024	2023	2022	2021	2020
Asset Turnover		0.7	0.5	0.4	0.2	0.1	·
Receivables Turnover		5.2	4.6	4.1	5.7	11.7	·

Hisse Başına 5

Metrik	2025	2024	2023	2022	2021	2020
Book Value / Share	$6.06	$4.67	$5.32	$3.84	$3.93	$5.78
Revenue / Share	$10.39	$7.09	$4.56	$2.27	·	·
Cash Flow / Share	$1.11	$0.22	$-1.74	$-3.54	·	·
Cash / Share	$5.72	$4.60	$6.13	$0.76	$1.02	$4.77
EPS (TTM)	$-0.47	$-1.85	$-4.00	$-4.02	$-2.77	·

Büyüme Oranları 2

Metrik	Eğilim	2025	2024	2023	2022	2021	2020
Revenue YoY		54.7%	80.8%	141.9%	302.7%	·	·
Revenue CAGR 3Y		89.1%	160.1%	·	·	·	·

Değerleme (TTM) 10

Metrik	2025	2024	2023	2022	2021	2020
Revenue TTM	$521M	$337M	$186M	$77M	$19M	$0
Net Income TTM	$-23M	$-88M	$-163M	$-136M	$-84M	$-103M
Market Cap	$4.10B	$2.00B	$1.38B	$721M	$488M	$520M
P/E	-168.1	-22.4	-7.4	-4.9	-5.8	·
P/S	7.9	5.9	7.4	9.4	25.5	·
P/B	13.0	8.9	5.5	5.1	4.1	3.0
P / Tangible Book	76.2	·	·	8.7	4.8	3.0
P / Cash Flow	73.4	193.6	-19.4	-6.0	-3.7	-5.8
P / FCF	74.7	214.2	-19.4	-6.0	-3.7	-5.8
Earnings Yield	-0.60%	-4.5%	-13.6%	-20.6%	-17.4%	·

Gelir Tablosu 14

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$176M	$160M	$149M	$133M	$128M	$112M	$99M	$90M	$78M	$69M	$70M	$48M	$37M	$32M	$28M	$19M
SG&A Expense	$81M	$96M	$74M	$62M	$63M	$58M	$57M	$51M	$49M	$46M	$46M	$37M	$33M	$30M	$26M	$23M
Operating Expenses	$219M	$949M	$153M	$130M	$133M	$127M	$124M	$103M	$102M	$96M	$102M	$73M	$62M	$59M	$62M	$52M
Operating Income	$-43M	$-789M	$-5M	$3M	$-5M	$-15M	$-24M	$-13M	$-24M	$-26M	$-33M	$-25M	$-24M	$-27M	$-34M	$-33M
Interest Income	$4M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$4M	$4M	$4M	$4M	$2M	$2M	$1M
Other Non-op	$-24M	$0	$-218.0K	$395.0K	$86.0K	$2M	$231.0K	$-1M	$312.0K	$2M	$-3M	$1M	$-274.0K	$-811.0K	$-588.0K	$-192.0K
Pretax Income	$-66M	$-790M	$-5M	$3M	$-5M	$-14M	$-24M	$-14M	$-24M	$-25M	$-35M	$-23M	$-74M	$-30M	$-36M	$-36M
Income Tax	$2M	$475.0K	$767.0K	$-262.0K	$402.0K	$1M	$-576.0K	$347.0K	$635.0K	$624.0K	$225.0K	$249.0K	$316.0K	$201.0K	$140.0K	$13.0K
Net Income	$-67M	$-790M	$-6M	$3M	$-6M	$-15M	$-24M	$-14M	$-25M	$-25M	$-36M	$-24M	$-74M	$-30M	$-36M	$-36M
EPS (Basic)	$-1.06	$-13.43	$-0.11	$0.06	$-0.12	$-0.30	$-0.49	$-0.30	$-0.52	$-0.54	$-0.69	$-0.57	$-1.94	$-0.80	$-0.98	$-1.02
EPS (Diluted)	$-1.06	$-13.43	$-0.10	$0.05	$-0.12	$-0.30	$-0.49	$-0.30	$-0.52	$-0.54	$-0.69	$-0.57	$-1.94	$-0.80	$-0.99	$-1.02
Shares (Basic)	63,374,183	58,851,021	·	50,639,231	49,726,823	48,889,058	·	47,782,619	47,235,080	46,927,550	·	41,098,920	38,107,334	37,675,306	·	34,927,790
Shares (Diluted)	63,374,183	58,851,021	·	56,993,841	49,726,823	48,889,058	·	47,782,619	47,235,080	46,927,550	·	41,098,920	38,107,334	37,675,306	·	34,927,790
EBITDA	$-43M	$-783M	·	$3M	$-5M	$-9M	·	$-13M	$-24M	$-21M	·	$-25M	$-24M	$-26M	·	$-33M

Bilanço 23

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$331M	$325M	$297M	$282M	$228M	$212M	$223M	$223M	$233M	$303M	·	$303M	$297M	$49M	·	$36M
Short-term Investments	$108M	$61M	$87M	$94M	$76M	$66M	$58M	$61M	$45M	·	·	$3M	$33M	$83M	·	$150M
Receivables	$145M	$133M	$123M	$107M	$107M	$96M	$78M	$69M	$60M	$55M	·	$48M	$35M	$25M	·	$16M
Inventory	$26M	$26M	$25M	$24M	$23M	$22M	$22M	$22M	$20M	$22M	·	$22M	$9M	$7M	·	$7M
Prepaid Expense	$27M	$25M	$18M	$24M	$19M	$15M	$12M	$12M	$9M	$10M	·	$12M	$10M	$9M	·	$7M
Current Assets	$636M	$569M	$550M	$531M	$453M	$411M	$393M	$387M	$368M	$389M	·	$389M	$384M	$172M	·	$216M
PP&E (Net)	$2M	$2M	$2M	$1M	$1M	$1M	$1M	$1M	$1M	$501.0K	·	$787.0K	$866.0K	$877.0K	·	$795.0K
Accum. Depreciation	·	·	$1M	·	·	·	$700.0K	·	·	·	·	·	·	·	·	·
Intangibles	$247M	$254M	$261M	$232M	$238M	$244M	$250M	$256M	$262M	$257M	·	$258M	$56M	$58M	·	$45M
Other Non-current Assets	$22M	$16M	$12M	$10M	$7M	$5M	$5M	$5M	$4M	$4M	·	$2M	$1M	$1M	·	$2M
Total Assets	$1.04B	$891M	$843M	$785M	$726M	$690M	$671M	$668M	$661M	$652M	·	$651M	$444M	$334M	·	$364M
Accounts Payable	$23M	$59M	$10M	$12M	$18M	$12M	$15M	$10M	$10M	$16M	·	$7M	$14M	$6M	·	$11M
Accrued Liabilities	·	·	$196M	·	·	·	$112M	$105M	$101M	$90M	·	$66M	$43M	$40M	·	$38M
Current Liabilities	$223M	$273M	$206M	$160M	$145M	$128M	$127M	$116M	$112M	$106M	·	$75M	$58M	$49M	·	$51M
Capital Leases	$10M	$11M	$8M	$7M	$8M	$7M	$8M	$8M	$8M	$328.0K	·	$868.0K	$1M	$1M	·	$1M
Other Non-current Liabilities	$11M	$6M	$5M	$16M	$9M	$14M	$3M	$4M	$4M	$4M	·	$7.0K	$10.0K	$772.0K	·	$4M
Total Liabilities	$1.06B	$648M	$528M	$493M	$471M	$457M	$445M	$436M	$432M	$417M	·	$382M	$365M	$192M	·	$195M
Common Stock	$6.0K	$6.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	·	$5.0K	$4.0K	$4.0K	·	$4.0K
Retained Earnings	$-1.52B	$-1.46B	$-668M	$-662M	$-665M	$-659M	$-644M	$-620M	$-606M	$-582M	·	$-521M	$-497M	$-423M	·	$-356M
AOCI	$-674.0K	$-28.0K	$351.0K	$37.0K	$352.0K	$-258.0K	$-373.0K	$920.0K	$-477.0K	$-13.0K	·	$-1M	$76.0K	$136.0K	·	$-413.0K
Stockholders' Equity	$-10M	$242M	$315M	$292M	$255M	$233M	$226M	$232M	$229M	$235M	$249M	$269M	$79M	$141M	$142M	$169M
Liabilities + Equity	$1.04B	$891M	$843M	$785M	$726M	$690M	$671M	$668M	$661M	$652M	·	$651M	$444M	$334M	·	$364M
Shares Outstanding	64,754,699	60,926,165	51,896,391	51,314,176	50,058,392	49,451,223	48,338,096	47,968,121	47,571,847	47,061,106	·	46,595,745	38,222,058	38,012,247	·	36,813,754

Nakit Akışı 13

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$7M	$7M	$6M	$6M	$6M	$6M	$6M	$6M	$6M	$6M	$5M	$3M	$1M	$1M	$1M	$1M
Stock-based Comp	$31M	$36M	$19M	$18M	$18M	$16M	$13M	$12M	$12M	$11M	$10M	$8M	$8M	$9M	$7M	$7M
Amort. of Intangibles	$7M	$7M	$6M	$6M	$6M	$6M	$6M	$6M	$6M	$6M	$5M	$3M	$1M	$1M	$1M	$1M
Other Non-cash	·	$518M	·	·	·	$-9M	·	·	·	$23M	·	·	·	$-14M	·	·
Operating Cash Flow	$-44M	$-229M	$6M	$40M	$12M	$-2M	$-5M	$4M	$-4M	$15M	$-17M	$-18M	$-2M	$-19M	$-34M	$-26M
CapEx	$23.0K	$664.0K	$600.0K	$187.0K	$126.0K	$41.0K	$20.0K	$181.0K	$779.0K	$13.0K	$0	$0	$68.0K	$41.0K	$242.0K	$19.0K
Investing Cash Flow	$-160M	$-12M	$1M	$-2M	$-7M	$-16M	$641.0K	$-18M	$-73M	$-13.0K	$-2M	$-183M	$36M	$27M	$27M	$-80M
Stock Issued	·	·	·	·	·	·	$0	$0	$0	$0	$0	$0	$0	$14M	$0	$0
Net Stock Activity	·	·	·	·	·	·	·	·	·	$0	·	·	·	$14M	·	·
Financing Cash Flow	$211M	$270M	$9M	$16M	$9M	$6M	$5M	$4M	$7M	$1M	$2M	$207M	$115M	$13M	$-329.0K	$86M
Net Change in Cash	$6M	$28M	$16M	$54M	$16M	$-11M	$-466.0K	$-10M	$-69M	$17M	$-17M	$6M	$148M	$21M	$-8M	$-20M
Taxes Paid	$907.0K	$220.0K	$6.0K	$504.0K	$1M	$162.0K	$233.0K	$432.0K	$200.0K	$139.0K	$125.0K	$0	$0	$0	·	·
Free Cash Flow	·	$-229M	·	·	·	$-2M	·	·	·	$15M	·	·	·	$-34M	·	·

Kârlılık 7

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-24.1%	-493.8%	·	2.0%	-3.9%	-13.6%	·	-14.0%	-31.1%	-38.2%	·	-52.7%	-64.7%	-85.9%	·	-175.1%
Net Margin	-38.1%	-494.2%	·	2.2%	-4.6%	-13.2%	·	-15.8%	-31.6%	-36.5%	·	-49.4%	-197.4%	-95.3%	·	-190.1%
Pretax Margin	-37.2%	-493.9%	·	2.0%	-4.3%	-12.2%	·	-15.4%	-30.8%	-35.6%	·	-48.9%	-196.6%	-94.7%	·	-190.1%
EBITDA Margin	-24.1%	-489.5%	·	2.0%	-3.9%	-8.2%	·	-14.0%	-31.1%	-30.0%	·	-52.7%	-64.7%	-81.7%	·	-175.1%
ROA	-7.6%	-100.0%	·	0.40%	-0.85%	-2.2%	·	-2.2%	-4.5%	-5.1%	·	-4.7%	-20.0%	-9.8%	·	-11.9%
ROE	-54.9%	-332.2%	·	1.1%	-2.4%	-6.3%	·	-5.7%	-16.0%	-13.5%	·	-10.8%	-78.2%	-24.1%	·	-31.6%
ROIC	418.7%	-325.8%	·	0.98%	-2.1%	-7.0%	·	-5.6%	-10.9%	-11.6%	·	-9.4%	-31.0%	-19.4%	·	-19.4%

Likidite ve Solventlik 2

Metrik	Eğilim	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio		2.9	2.1	·	3.3	3.1	3.2	·	3.3	3.3	3.7	·	5.2	6.6	3.5	·	4.2
Quick Ratio		2.6	1.9	·	3.0	2.8	2.9	·	3.0	3.0	3.4	·	4.7	6.3	3.2	·	3.9

Verimlilik 2

Metrik	Eğilim	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.2	0.2	·	0.2	0.2	0.2	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1
Receivables Turnover		1.4	1.4	·	1.5	1.5	1.5	·	1.6	1.6	1.7	·	1.5	1.5	1.9	·	2.3

Hisse Başına 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$-0.16	$3.98	·	$5.69	$5.10	$4.72	·	$4.84	$4.81	$4.99	·	$5.77	$2.06	$3.71	·	$4.60
Revenue / Share	$2.78	$2.72	·	$2.33	$2.57	$2.28	·	$1.89	$1.65	$1.48	·	$1.16	$0.98	$0.84	·	$0.54
Cash Flow / Share	·	$-3.89	·	·	·	$-0.04	·	·	·	$0.32	·	·	·	$-0.90	·	·
Cash / Share	$5.11	$5.33	·	$5.50	$4.56	$4.28	·	$4.65	$4.90	$6.44	·	$6.50	$7.78	$1.30	·	$0.97
EPS (TTM)	$-14.54	$-13.60	·	$-0.86	$-1.21	$-1.61	·	$-2.05	$-2.32	$-3.74	·	$-4.30	$-4.75	$-3.65	·	$-1.12

Değerleme (TTM) 9

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$618M	$570M	·	$472M	$429M	$379M	·	$307M	$264M	$224M	·	$145M	$116M	$96M	·	$52M
Net Income TTM	$-860M	$-799M	·	$-41M	$-59M	$-77M	·	$-100M	$-109M	$-159M	·	$-164M	$-176M	$-129M	·	$-42M
Market Cap	$7.58B	$5.63B	·	$3.76B	$2.55B	$2.23B	·	$1.87B	$1.63B	$1.18B	·	$1.47B	$989M	$913M	·	$773M
P/E	-8.1	-6.8	·	-85.2	-42.1	-28.0	·	-19.0	-14.7	-6.7	·	-7.3	-5.4	-6.6	·	-18.8
P/S	12.3	9.9	·	8.0	5.9	5.9	·	6.1	6.2	5.3	·	10.2	8.5	9.5	·	14.8
P/B	-727.4	23.2	·	12.9	10.0	9.6	·	8.1	7.1	5.0	·	5.5	12.6	6.5	·	4.6
P / Tangible Book	·	·	·	62.5	147.4	·	·	·	·	·	·	137.1	44.6	10.9	·	6.2
P / Cash Flow	·	-24.6	·	·	·	-1136.0	·	·	·	77.7	·	·	·	-27.0	·	·
Earnings Yield	-12.4%	-14.7%	·	-1.2%	-2.4%	-3.6%	·	-5.3%	-6.8%	-14.9%	·	-13.6%	-18.4%	-15.2%	·	-5.3%

En son dönem solda · null değerler · olarak gösterilir

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

16

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Gelir	$521M	$337M	$186M	$77M	$19M
Faaliyet Kâr Marjı %	-4.2%	-26.0%	-58.6%	-170.3%	-906.1%
Net Gelir	$-23M	$-88M	$-163M	$-136M	$-84M
Seyreltilmiş Hisse Başı Kâr	$-0.47	$-1.85	$-4.00	$-4.02	$-2.77

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Cari Oran	2.7	3.1	4.5	2.9	3.9
Cari Oran	2.5	2.8	4.1	2.7	3.8

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Serbest Nakit Akışı	$55M	$9M	$-71M	$-120M	$-133M

Kurumsal Sahipler (13F) 346 dosya · $8.2B toplam · Tarih itibarıyla 30 Eylül 2026

17

Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.

Sahipler 346

Tutulan Değer $8.2B

Yeni pozisyonlar 62

Çıkan pozisyonlar 41

Kurumsal faaliyet — Q2 2026 ve önceki çeyrek

Yeni pozisyonlar	Çıkan pozisyonlar	Artırıldı	Azaldı	Net hisse senedi değişimi
62 (-11 önceki Ç'ye göre)	41 (+10 önceki Ç'ye göre)	126 (+12 önceki Ç'ye göre)	98 (+11 önceki Ç'ye göre)	-2.9M

Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.

Kurum	Değer	Hisse senetleri	% izlenen 13F'nin	Tür
Frazier Life Sciences Management, L.P.	$899.060.606	7.679.684	11,02%	Hisse senetleri
JANUS HENDERSON GROUP PLC	$641.764.403	6.945.813	7,86%	Hisse senetleri
BlackRock, Inc.	$513.944.677	4.390.063	6,30%	Hisse senetleri
FMR LLC	$429.683.688	3.670.314	5,26%	Hisse senetleri
VANGUARD PORTFOLIO MANAGEMENT LLC	$278.277.614	2.377.019	3,41%	Hisse senetleri
VANGUARD CAPITAL MANAGEMENT LLC	$263.888.541	2.254.109	3,23%	Hisse senetleri
STATE STREET CORP	$254.122.561	2.170.689	3,11%	Hisse senetleri
VANGUARD GROUP INC	$205.065.069	2.596.089	2,51%	Hisse senetleri
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	$164.453.029	1.404.741	2,02%	Hisse senetleri
GEODE CAPITAL MANAGEMENT, LLC	$163.213.962	1.393.908	2,00%	Hisse senetleri
Invesco Ltd.	$159.693.314	1.364.084	1,96%	Hisse senetleri
WELLINGTON MANAGEMENT GROUP LLP	$153.360.177	1.309.987	1,88%	Hisse senetleri
EVENTIDE ASSET MANAGEMENT, LLC	$146.202.247	1.248.389	1,79%	Hisse senetleri
TANG CAPITAL MANAGEMENT LLC	$144.701.681	1.236.027	1,77%	Hisse senetleri
Capital World Investors	$135.037.904	1.153.480	1,65%	Hisse senetleri
FRANKLIN RESOURCES INC	$134.954.787	1.152.770	1,65%	Hisse senetleri
NOVO HOLDINGS A/S	$131.703.750	1.125.000	1,61%	Hisse senetleri
TCG Crossover Management, LLC	$124.334.076	1.062.049	1,52%	Hisse senetleri
BVF INC/IL	$123.629.081	1.056.027	1,51%	Hisse senetleri
Polar Capital Holdings Plc	$98.985.495	845.524	1,21%	Hisse senetleri
Rock Springs Capital Management LP	$93.438.835	798.145	1,14%	Hisse senetleri
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.	$88.042.000	752.044	1,08%	Hisse senetleri
AMERIPRISE FINANCIAL INC	$85.074.348	726.694	1,04%	Hisse senetleri
TWO SIGMA INVESTMENTS, LP	$80.815.528	690.318	0,99%	Hisse senetleri
Bank of New York Mellon Corp	$78.433.863	669.974	0,96%	Hisse senetleri
Clearbridge Investments, LLC	$74.893.623	639.734	0,92%	Hisse senetleri
BNP PARIBAS FINANCIAL MARKETS	$70.994.409	606.427	0,87%	Hisse senetleri
Woodline Partners LP	$66.483.351	567.894	0,81%	Hisse senetleri
BANK OF AMERICA CORP /DE/	$65.761.029	561.724	0,81%	Hisse senetleri
GOLDMAN SACHS GROUP INC	$64.373.750	549.874	0,79%	Hisse senetleri
Pictet Asset Management Holding SA	$61.630.682	526.443	0,76%	Hisse senetleri
Balyasny Asset Management L.P.	$57.267.132	489.170	0,70%	Hisse senetleri
EMERALD ADVISERS, LLC	$54.823.296	468.295	0,67%	Hisse senetleri
NORTHERN TRUST CORP	$52.919.855	452.036	0,65%	Hisse senetleri
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$52.614.653	449.429	0,64%	Hisse senetleri
BAKER BROS. ADVISORS LP	$52.210.293	445.975	0,64%	Hisse senetleri
LOOMIS SAYLES & CO L P	$51.936.466	443.636	0,64%	Hisse senetleri
RENAISSANCE TECHNOLOGIES LLC	$51.766.598	442.185	0,63%	Hisse senetleri
FEDERATED HERMES, INC.	$51.116.860	436.635	0,63%	Hisse senetleri
NEXT CENTURY GROWTH INVESTORS LLC	$49.194.335	420.213	0,60%	Hisse senetleri
Connor, Clark & Lunn Investment Management Ltd.	$49.176.775	420.063	0,60%	Hisse senetleri
BOONE CAPITAL MANAGEMENT LLC	$48.659.092	415.641	0,60%	Hisse senetleri
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	$45.021.610	384.570	0,55%	Hisse senetleri
UBS Group AG	$44.458.503	379.760	0,54%	Hisse senetleri
Candriam S.C.A.	$43.992.694	376.143	0,54%	Hisse senetleri
MORGAN STANLEY	$41.138.902	351.404	0,50%	Hisse senetleri
ADAGE CAPITAL PARTNERS GP, L.L.C.	$40.974.500	350.000	0,50%	Hisse senetleri
Palo Alto Investors LP	$40.834.953	348.808	0,50%	Hisse senetleri
VANGUARD FIDUCIARY TRUST CO	$40.767.286	348.230	0,50%	Hisse senetleri
Octagon Capital Advisors LP	$39.675.023	338.900	0,49%	Hisse senetleri

Tüm 346 kurumsal sahibi göster →

Aktivistler ve %5+ sahipler 7 pozisyon

18

SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.

Başvuru sahibi	Dosyalandı	Hisse	Durum	Amaç	Başvuru
Frazier Life Sciences IX, L.P., FHMLS IX, L.P., FHMLS IX, L.L.C., Frazier Life Sciences X, L.P., FHMLS X, L.P., FHMLS X, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., Frazier Life Sciences XII, L.P., FHMLS XII, L.P., FHMLS XII, L.L.C., James N. Topper, Patrick J. Heron ×9 başvurular	27 Ocak 2026	6,80%	Değişiklik	Pasif yatırım	SEC
	29 Aralık 2023	·	İlk başvuru	·	SEC
New Enterprise Associates 16, L.P., NEA Partners 16, L.P., NEA 16 GP, LLC, Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell, Paul Walker ×2 başvurular	23 Haziran 2023	·	İlk başvuru	·	SEC
Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi	01 Aralık 2022	·	İlk başvuru	·	SEC
Novo Holdings A/S ×7 başvurular	18 Ağustos 2022	·	İlk başvuru	·	SEC
Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi	22 Aralık 2020	·	İlk başvuru	·	SEC
Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi	01 Ağustos 2019	·	İlk başvuru	Pasif yatırım	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Şirket yöneticileri 33 içeriden öğrenenler · 9 yöneticiler · 12 yönetim kurulu üyeleri

19

İçeriden Öğrenen	Rol	Son işlem	Sahip olunan hisse senetleri	Alımlar 12ay	Satışlar 12ay	Net 12ay
Christopher Peetz	CHIEF EXECUTIVE OFFICER	01 Eylül 2026 M	194.440	0	19	$-16.289.473
Eric Bjerkholt	CHIEF FINANCIAL OFFICER	11 Eylül 2026 M	44.745	0	12	$-3.562.112
Ian Clements	Chief Financial Officer	10 Kasım 2022 A	30.011	0	0	$0
Peter Radovich	PRESIDENT AND COO	05 Haziran 2026 M	57.260	0	4	$-2.315.469
Jolanda Howe	SVP, GLOBAL CONTROLLER	02 Eylül 2026 S	616	0	9	$-5.553.171
Joanne Quan	CHIEF MEDICAL OFFICER	15 Mart 2026 M	18.864	0	3	$-1.464.161
Pamela Vig	CHIEF SCIENTIFIC OFFICER	24 Haziran 2024 M	27.406	0	0	$0
Lara Longpre	CHIEF DEVELOPMENT OFFICER	09 Ocak 2023 S	104.369	0	0	$0
Edwin Jonathan Tucker	Chief Medical Officer	10 Kasım 2021 A	45.838	0	0	$0
Lon Cardon	Yönetim kurulu üyesi	15 Haziran 2026 A	9.680	0	0	$0
William Fairey	Yönetim kurulu üyesi	15 Haziran 2026 A	2.500	0	0	$0
Saira Ramasastry	Yönetim kurulu üyesi	15 Haziran 2026 A	0	0	9	$-1.917.580
Laurent Fischer	Yönetim kurulu üyesi	15 Haziran 2026 A	10.727	0	0	$0
Laura Brege	Yönetim kurulu üyesi	15 Haziran 2026 A	15.703	0	0	$0
Patrick J. Heron	Yönetim kurulu üyesi	15 Haziran 2026 A	459.010	1	0	$8.999.984
Timothy P Walbert	Yönetim kurulu üyesi	15 Haziran 2026 A	9.680	0	0	$0
Michael G Grey	Yönetim kurulu üyesi	15 Haziran 2026 A	0	0	3	$-11.100.000
Niall O'Donnell, Ph.D.	Yönetim kurulu üyesi	15 Kasım 2022 S	1.621.118	0	0	$0
Carol L Brosgart	Yönetim kurulu üyesi	02 Haziran 2022 A	·	0	0	$0
Edward T. Mathers	Yönetim kurulu üyesi	02 Haziran 2022 A	·	0	0	$0
Carmen Chang	10% sahip	13 Haziran 2023 J	135	0	0	$0
New Enterprise Associates 16, L.P.	10% sahip	13 Haziran 2023 J	2.186.243	0	0	$0
Mohamad Makhzoumi	10% sahip	13 Haziran 2023 J	11.348	0	0	$0
Ali Behbahani	10% sahip	13 Haziran 2023 J	135	0	0	$0
Anthony A. Florence, Jr.	10% sahip	13 Haziran 2023 J	11.348	0	0	$0
Paul Walker	10% sahip	13 Haziran 2023 J	114	0	0	$0
Forest Baskett	10% sahip	13 Haziran 2023 J	1.548	0	0	$0
Scott D. Sandell	10% sahip	13 Haziran 2023 J	11.348	0	0	$0
Peter W. Sonsini	10% sahip	22 Temmuz 2019 C	4.186.243	0	0	$0
Novo Holdings A/S	10% sahip	22 Temmuz 2019 C	2.445.147	0	0	$0
Joshua Makower	10% sahip	22 Temmuz 2019 C	4.186.243	0	0	$0
David M Mott	10% sahip	22 Temmuz 2019 C	4.186.243	0	0	$0
Peter J Barris	10% sahip	22 Temmuz 2019 C	4.186.243	0	0	$0

SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış

ETF sahipliği 37 ETF'ler tarafından tutuluyor

20

Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.

Fon	Ağırlık	Birimler	Tarih itibarıyla	Kaynak
BBP · ETFis Series Trust I	1,47%	13.661 NS	31 Temmuz 2026	N-PORT
LABU · Direxion Shares ETF Trust	0,77%	35.899 NS	31 Temmuz 2026	N-PORT
FNY · First Trust Exchange-Traded AlphaDE…	0,58%	31.362 NS	31 Temmuz 2026	N-PORT
ESSC · Strategy Shares	0,39%	1.309 NS	31 Temmuz 2026	N-PORT
IBB · iShares Trust	0,37%	379.636 SH	11 Eylül 2026	Günlük
IBBQ · Invesco Exchange-Traded Fund Trust …	0,36%	4.593 SH	01 Ekim 2026	Günlük
VTWG · VANGUARD SCOTTSDALE FUNDS	0,33%	50.804 SH	19 Ağustos 2026	Günlük
IWO · iShares Trust	0,31%	445.371 SH	11 Eylül 2026	Günlük
FNX · First Trust Exchange-Traded AlphaDE…	0,27%	35.193 NS	31 Temmuz 2026	N-PORT
BKSE · BNY Mellon ETF Trust	0,24%	2.013 NS	31 Temmuz 2026	N-PORT
PWS · Pacer Funds Trust	0,22%	490 NS	31 Temmuz 2026	N-PORT
ROSC · Lattice Strategies Trust	0,20%	1.161 NS	31 Temmuz 2026	N-PORT
BBSC · J.P. Morgan Exchange-Traded Fund Tr…	0,18%	12.040 NS	31 Temmuz 2026	N-PORT
FAD · First Trust Exchange-Traded AlphaDE…	0,17%	9.414 NS	31 Temmuz 2026	N-PORT
VBK · VANGUARD INDEX FUNDS	0,17%	686.321 SH	19 Ağustos 2026	Günlük
VTWO · VANGUARD SCOTTSDALE FUNDS	0,17%	273.231 SH	19 Ağustos 2026	Günlük
RSSL · Global X Funds	0,16%	22.732 NS	31 Temmuz 2026	N-PORT
IWM · iShares Trust	0,16%	1.212.070 SH	11 Eylül 2026	Günlük
ISCG · iShares Trust	0,15%	14.024 SH	11 Eylül 2026	Günlük
FSMD · FIDELITY COVINGTON TRUST	0,14%	32.141 NS	31 Temmuz 2026	N-PORT
VFMO · VANGUARD WELLINGTON FUND	0,11%	18.506 SH	19 Ağustos 2026	Günlük
VB · VANGUARD INDEX FUNDS	0,07%	1.188.816 SH	19 Ağustos 2026	Günlük
VHT · VANGUARD WORLD FUND	0,07%	126.877 SH	19 Ağustos 2026	Günlük
OMFS · Invesco Exchange-Traded Self-Indexe…	0,06%	1.996 SH	01 Ekim 2026	Günlük
FHLC · FIDELITY COVINGTON TRUST	0,06%	20.071 NS	31 Temmuz 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,06%	552.499 SH	19 Ağustos 2026	Günlük
ESML · iShares Trust	0,05%	14.579 SH	11 Eylül 2026	Günlük
PRFZ · Invesco Exchange-Traded Fund Trust	0,04%	12.650 SH	01 Ekim 2026	Günlük
WSML · iShares Trust	0,04%	2.608 SH	11 Eylül 2026	Günlük
VTI · VANGUARD INDEX FUNDS	0,01%	1.648.584 SH	19 Ağustos 2026	Günlük
VTHR · VANGUARD SCOTTSDALE FUNDS	0,01%	3.912 SH	19 Ağustos 2026	Günlük
ITOT · iShares Trust	0,01%	62.879 SH	11 Eylül 2026	Günlük
IWV · iShares Trust	0,01%	12.733 SH	11 Eylül 2026	Günlük
TILT · FlexShares Trust	0,01%	1.296 NS	31 Temmuz 2026	N-PORT
ISCB · iShares Trust	·	1.994 SH	11 Eylül 2026	Günlük
SMLF · iShares Trust	·	54.129 SH	11 Eylül 2026	Günlük
SMMV · iShares Trust	·	7.592 SH	19 Ağustos 2026	Günlük

MIRM Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

21

derecelendirme · 20 analist AL

Medyan hedef $138.50 +67,0%

8 40,0% Güçlü Al

11 55,0% Al

1 5,0% Tut

0 0,0% Sat

0 0,0% Güçlü Sat

12 Aylık Fiyat Hedefi

14 analist · 2026-09-29

Ortalama hedef $145.79 +75,8%

← Tüm hedeflerin altında Mevcut fiyat $82.93

Düşük$118.00 Ortalama$145.79 Yüksek$195.00

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

22

Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.

Hisse Sembolü	Piyasa Değeri	P/E	Gelir YoY	Net Kar Marjı	ROE	Brüt Kar Marjı
MIRM	$4.10B	-168.1	54.7%	-4.5%	-8.2%	·
SRRK	$4.78B	-13.4	·	·	-157.9%	·
KOD	$1.73B	-6.5	·	·	-202.0%	·
ORKA	$1.48B	-3.3	·	·	-25.9%	·
COGT	$5.72B	-16.4	·	·	-83.1%	·
TVTX	$3.47B	-131.8	110.5%	-5.2%	-34.6%	·
PTCT	$6.19B	9.8	114.5%	39.4%	-331.5%	·
ERAS	$1.06B	-8.5	·	·	-35.7%	·
DNTH	$1.78B	-9.8	-67.3%	-7973.3%	-40.8%	·

Son Haberler Bu şirketten bahseden son manşetler

23

Mirum Pharma (MIRM) Kazanç Çağrısı Dökümü Yahoo Finance · 6 ay önce Hedge Fund Boone Capital, HealthEquity'de Bir Pay Başlattı. Hisse Satın Alınır mı? Yahoo Finance · 6 ay, 2 hafta önce

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

26

Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

MIRM Mirum Pharmaceuticals, Inc. - common stock